Abcam PLC operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abcam PLC with three other
pharmaceutical manufacturers in Europe:
Summit Therapeutics PLC
(2019
sales of £43.01 million [US$53.56 million]
of which 100%
was Drug Discovery),
Eco Animal Health Group Plc
(£74.58 million [US$92.87 million]
of which 38%
was China & Japan), and
Dottikon ES Holding AG
which is
based in Switzerland
(147.71 million Swiss Francs [US$149.05 million]
of which 100%
was The pharmaceutical).
Sales Analysis.
Abcam PLC reported sales of £259.90 million (US$323.66 million)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 11.4%
versus 2018, when the company's sales were £233.20 million.
Sales at Abcam PLC have increased during each of the previous five years
(and since 2014, sales have increased a total of 103%).